CAsubtype: An R Package to Identify Gene Sets Predictive of Cancer Subtypes and Clinical Outcomes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CAsubtype: An R Package to Identify Gene Sets Predictive of Cancer Subtypes and Clinical Outcomes
Authors
Keywords
Cancer subtype, Clinical outcome, R package, Gene signature, Gene expression profile
Journal
Interdisciplinary Sciences-Computational Life Sciences
Volume 10, Issue 1, Pages 169-175
Publisher
Springer Nature
Online
2017-01-21
DOI
10.1007/s12539-016-0198-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene expression analysis identifies global gene dosage sensitivity in cancer
- (2015) Rudolf S N Fehrmann et al. NATURE GENETICS
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Denoising perturbation signatures reveal an actionable AKT-signaling gene module underlying a poor clinical outcome in endocrine-treated ER+ breast cancer
- (2015) Andrew E Teschendorff et al. GENOME BIOLOGY
- Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
- (2014) T. Z. Tan et al. EMBO Molecular Medicine
- The REST Gene Signature Predicts Drug Sensitivity in Neuroblastoma Cell Lines and Is Significantly Associated with Neuroblastoma Tumor Stage
- (2014) Jianfeng Liang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes
- (2014) Sharmistha Pal et al. NUCLEIC ACIDS RESEARCH
- Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients
- (2013) N. Rapin et al. BLOOD
- EMT is the dominant program in human colon cancer
- (2013) Andre Loboda et al. BMC Medical Genomics
- Prognostic impact of EMT (epithelial-mesenchymal-transition)-related protein expression in endometrial cancer
- (2013) Yoshimichi Tanaka et al. CANCER BIOLOGY & THERAPY
- Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions
- (2013) Felipe De Sousa E Melo et al. NATURE MEDICINE
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy
- (2013) Anguraj Sadanandam et al. NATURE MEDICINE
- A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients
- (2013) UnJin Lee et al. PLoS One
- Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
- (2013) Laetitia Marisa et al. PLOS MEDICINE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
- (2012) H. Zouridis et al. Science Translational Medicine
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Making sense of cancer genomic data
- (2011) Lynda Chin et al. GENES & DEVELOPMENT
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
- (2009) Steffen Durinck et al. Nature Protocols
- What is principal component analysis?
- (2008) Markus Ringnér NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation